Search
Now showing items 1-1 of 1
Serum sTWEAK and FGF-23 levels in hemodialysis and renal transplant patients
(2017)
Background: Kidney transplantation is the treatment of choice for patients with end-stage renal disease. Objective: To evaluate the changes in serum soluble TNF-like weak inducer of apoptosis (sTWEAK) and fibroblast growth ...